Home › Multipel myeloom › Texas › Austin
Multipel myeloom klinische studies in Austin, TX
8 studies voor Multipel myeloom zoeken deelnemers op locaties in en rond Austin (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekruterenFase 3
- Research Site, Austin
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 3
- St. David's South Austin Medical Center, Austin
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekruterenFase 1/2
- Research Site, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
RekruterenFase 4
- St. David's South Austin Medical Center, Austin
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruterenFase 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruterenFase 2
- Texas Oncology, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Elligo Health Research, Inc., Austin
Multipel myeloom studies in andere steden
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Andere studies in Austin
- Niet-kleincellige longkanker30 studies
- Kanker (alle vormen)20 studies
- Obesitas20 studies
- Metastatische kanker19 studies
- Colorectale kanker19 studies
- Hartfalen18 studies
- Borstkanker18 studies
- Overgewicht18 studies
- Eierstokkanker17 studies
- Endometriumkanker15 studies
- Prostaatkanker15 studies
- Depressie14 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.